T he heart failure literature is filled with a growing body of research that has identified an array of signaling pathways, transcription factors, noncoding ribonucleic acids (micro-and long noncoding ribonucleic acids), and genetic variants that are associated with either the presence and/or severity of heart failure. Although these findings often constitute important and seminal observations, such studies are limited in that they are essentially hypothesis-generating and do not establish causal relationships. Moreover, it remains challenging to dissect the mechanistic elements that ultimately govern how a particular molecule exerts its effects on the human myocardium. Most investigators have turned to rodent models to address these issues; however, it has become apparent that vast differences exist between human and model organisms (1,2).
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In an effort to overcome these limitations, Although the findings of Thomas et al. (7) have provided a potentially exciting avenue to approach human translational cardiovascular biology with a more mechanistic mindset, it is likely that substantial research remains to better refine human heart slice culture systems and more adequately define their limitations. Future studies will ultimately be required to decipher the optimal conditions for slice preparation, determine the duration that slices can be cultured, and define the range of variability seen within and between specimens. To date, there are few reports of human heart slice culture (10) (11) (12) . One group used septal myectomy specimens and a different slicing apparatus (10) . Intriguingly, they reported that slices could survive for up to 4 weeks in culture, albeit with altered tissue morphology. As more investigators adopt slice culture systems, the strengths, weaknesses, and optimal uses of these preparations will be better defined, including adaptation of culture conditions that most closely resemble endogenous myocardial tissue.
Most importantly, the continued development of experimental systems to study human cardiac biology will ultimately provide the missing link necessary to establish the requisite causal relationships and molecular mechanisms that underlie the pathogenesis of human cardiac disease. Such insights will be essential to efficiently and successfully develop novel therapies that could ultimately be translated into clinical practice.
